 |
 |
PDtrials.org Bulletin - July 2005 Clinical Trial Information and News for the Parkinson’s Community Thank you for signing up to receive the Advancing Parkinson’s Therapies (APT) PDtrials.org Bulletin. This email communication provides information on Parkinson’s disease clinical trials that are actively looking for participants, as well as news of interest on research and treatments. In this issue: Trials Recently Added to PDtrials.org A Caregiver Testimonial on the Value of PDtrials.org PDtrials News Avigen Announces Encouraging Early Data from AV201 Trial ACADIA Announces Positive Interim Results on ACP-103 Phase II Trial Take the CISCRP Clinical Trial Registry Survey Trials Recently Added to PDtrials.org Stress-Reducing Program for Caregivers of People with Brain Conditions Family caregivers provide a valuable service for their relatives. While doing so, caregivers sometimes encounter physical and emotional stress that can be challenging. This study hopes to introduce some effective stress management techniques for family caregivers. Learn more… A Caregiver Testimonial on the Value of PDtrials.org We've been thrilled by the stories that we have received from people who have found www.PDtrials.org to be a key resource on clinical trials. Here is an excerpt of an email we received from a daughter who is caring for her mom: “My mother has been involved in a study that I found using your web site…the best part was not only was she compensated for her time but the study provided cab fare… I was receiving your e-mails and I looked up all the studies and found her some where she would not have to stop taking the medication she is already on. I just thought you should know someone out there not only reads your newsletters but actually follows through and gets involved in the research.” Sandra Fogel lives in Maryland and is caregiver to her mother who has Parkinson's. If you have found www.PDtrials.org to be useful and want to share your experience, please email us at [log in to unmask] PDtrials.org News Avigen Announces Encouraging Early Data from AV201 trial Avigen, Inc. announced encouraging results from the first person who was treated in an early phase clinical trial of AV201, the company's drug candidate for the treatment of mid- to later-stage Parkinson's disease. Read more… ACADIA Announces Positive Interim Results on ACP-103 Phase II Trial ACADIA Pharmaceuticals, Inc. reported encouraging results from a planned interim trend analysis on ACP-103 trial for treatment-induced psychosis in Parkinson’s patients. Read more… Take the CISCRP Clinical Trial Registry Survey CISCRP (The Center for Information and Study on Clinical Research Participation) is conducting a survey among people who have looked at listings of clinical trials over the Internet. Your input will be valuable in helping us to better understand how people use resources like www.PDtrials.org and how the delivery of this information can be improved. Your opinions are completely confidential and private. View the survey… Spread the word about the Advancing Parkinson’s Therapies Campaign and www.PDtrials.org! If your organization serves the Parkinson’s community, you may wish to join forces with us in increasing awareness and education about clinical trials. There are a number of ways to get involved, such as distributing educational materials, featuring an APT booth at a local event, or being listed on the on the Campaign Partners page on PDtrials.org. Please contact us at [log in to unmask] to find out more. APT is led by the Parkinson’s Disease Foundation in collaboration with the American Parkinson Disease Association, the Michael J. Fox Foundation for Parkinson’s Research, the National Parkinson Foundation, the Parkinson’s Action Network, The Parkinson Alliance, and WE MOVE. In addition, APT has a collaborative relationship with the National Institute of Neurological Disorders and Stroke, the Parkinson Study Group, and the Parkinson Pipeline Project. Our success depends on your support. If you know someone who would be interested in receiving information about Parkinson’s clinical research, please forward this email. Subscribe! If you have been forwarded this message and would like to sign-up for regular email updates from PDtrials.org, please go to http://www.pdtrials.org/email_notification.php. ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn